Ketogenic Diet & Functional Recovery in Moderate to Severe Traumatic Brain Injury
Key facts
- Who runs it
- Loma Linda University
- Where
- Loma Linda, United StatesSee the site
- Trial code
- Status
- Completed
- People taking part
- 21 people enrolled
- Started
- 7 Dec 2020
- Ended
- 14 Aug 2025
- Type of study
- Interventional, 2 groupsOne group gets a sham (pretend) treatment, for comparison.
- Treatments tested
- ketogenic/modified Atkins diet
- Standard diet
- Record updated
- 4 February 2026
Who can take part
- Age
- 16 years to 90 years
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 18 criteriaShow less
Who can take part
- complicated mild (GCS 13-15), moderate (GCS 9 - 12) to severe (GCS ≤ 8) traumatic brain injury (TBI) between 2-30 days post injury
- Admitted to Loma Linda University surgical intensive care unit (SICU)
Who cannot take part
- abdominal surgery during the same admission
- history of comorbid ischemic stroke following qualifying TBI
- history of premorbid brain injury with associated loss of consciousness
- history of psychiatric disorder
- history of premorbid neurological disorder or neurosurgical intervention
- acute renal failure according to the Risk, Injury, Failure, Loss of kidney function, and End-stage kidenty disease (RIFLE) classification
- type 1 diabetes
- known history of metabolic disorders that are a contradiction for ketogenic diet (KD) such as primary carnitine deficient, carnitine palmitoyltransferase (CPT) I or II deficiency, carnitine translocase deficiency, beta-oxidation defects, pyruvate carboxylase deficiency, or porphyria
- prealbumin (transthyretin) levels of <10 mg/dL within 3 days of admission
- pregnancy
- depressed GCS score due to acute intoxication
- liver dysfunction as defined by liver enzymes 5 times the upper limit of normal or chronic cirrhosis
- gastroparesis
- dyslipidemia
- severe asphasia
- Metal, implanted device (ICP monitor), pregnancy, claustrophobia, or other contraindication to MRI
Where in United States
- Loma Linda University HealthLoma Linda, United States
About the trial
What the trial wants to find out
Traumatic Brain Injury (TBI) represents a significant public health risk in the United States leaving many survivors with significant long term cognitive deficits and at risk for neurodegenerative diseases. Despite extensive research there are no pharmacological therapies which have demonstrated significant improvement in neurological or cognitive recovery. Changes in glucose metabolism are considered the hallmark metabolic response to TBI and ketosis has been proposed as a therapy to ameliorate metabolic dysfunction. This trial investigates the therapeutic potential of a ketogenic or modified Atkins diet on neurocognitive outcome following moderate-severe TBI.
The 2 groups in the trial
- TBI KD/MADTreatment being tested
TBI subjects on a ketogenic/modified Atkins diet
Treatment: ketogenic/modified Atkins diet
- TBI SDSham treatment, for comparison
TBI subjects on a standard (normal) diet
Treatment: Standard diet
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Record updated
- 4 February 2026